Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 4Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 9Other hematologic neoplasm 2Gynecologic 2Genitourinary 2Thoracic 1Myeloid 1CNS 1Breast 1

Conditions

Ovarian Cancer Prevention 1Fallopian Tube Neoplasms 1

Interventions

pembrolizumab 45Paclitaxel 45Carboplatin 39Magnetic Resonance Spectroscopy 28olaparib 27Specimen Handling 26Cisplatin 24Bevacizumab 20Nivolumab 18Taxes 17Biopsy 16Gemcitabine 13Cyclophosphamide 13durvalumab 12Immunoglobulin G 11Doxorubicin 11Disulfides 11Surveys and Questionnaires 10niraparib 9liposomal doxorubicin 9dostarlimab 9Radiotherapy 8Brachytherapy 8lenvatinib 7fludarabine 7atezolizumab 7Letrozole 7Docetaxel 7cediranib 6Platinum 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Aspirin × Gynecologic × Clear all
NCT03771651 2026-02-17

Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube

University of Oklahoma

Phase EARLY_PHASE1 Active not recruiting
18 enrolled
Gynecologic

Fallopian Tube Neoplasms

NCT03480776 2026-01-14

ASA in Prevention of Ovarian Cancer (STICs and STONEs)

Canadian Cancer Trials Group

Phase 2 Active not recruiting
117 enrolled
Gynecologic

Ovarian Cancer Prevention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡